Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
24
2024
High Expectations: New Jersey’s Rocky Road to Cannabis Consumption Lounges Norris McLaughlin P.A.
Jan
23
2024
Select Highlights from CY 24 Medicare Physician Fee Schedule Final Rule Polsinelli PC
Jan
23
2024
Trending in Telehealth: January 4 – 15, 2024 McDermott Will & Emery
Jan
23
2024
Fiji Water Maker Sued Over Microplastics Keller and Heckman LLP
Jan
23
2024
Florida PBM Law Limits Mail-Order Prescription Drug Programs, Requires State Filings by Employer Plans Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jan
22
2024
Gold Dome Report – Legislative Day 6 (2024) Nelson Mullins
Jan
22
2024
Federal Judge Rejects Pharma Manufacturers’ Challenge to Negative OIG Advisory Opinion Mintz
Jan
22
2024
Tips for Alcohol Suppliers Utilizing Social Media McDermott Will & Emery
Jan
21
2024
FDA Issues Final Rule and Guidance on Direct-To-Consumer Prescription Drug Advertisements Sheppard, Mullin, Richter & Hampton LLP
Jan
19
2024
Iowa Employers Must Ensure Strict Adherence to State’s Drug Testing Law Jackson Lewis P.C.
Jan
19
2024
This Week in 340B: January 9 – 16, 2024 McDermott Will & Emery
Jan
19
2024
Sponsored Genetic Testing Programs: Compliance Considerations Following DOJ False Claims Act Settlement Epstein Becker & Green, P.C.
Jan
19
2024
McDermottPlus Check-Up: January 19, 2024 McDermott Will & Emery
Jan
18
2024
Federal Circuit Affirms Skinny Label Carve Outs Sheppard, Mullin, Richter & Hampton LLP
Jan
18
2024
Shazam! Captain Cannabis Registration Defeated by Prior Analogous Trademark Use McDermott Will & Emery
Jan
18
2024
PTO Continues to Wave Wands in Assessing Enablement McDermott Will & Emery
Jan
18
2024
Ordinary Meaning: “Identifying” Doesn’t Mean Detecting; It Means Identifying McDermott Will & Emery
Jan
18
2024
China Solicits Comments on Food-Contact Coatings Standard Keller and Heckman LLP
Jan
18
2024
Quaker Oats Expands Recall to Cap’n Crunch Products Keller and Heckman LLP
Jan
17
2024
HSE Recommends Adding DIHxP to UK REACH Authorization List Bergeson & Campbell, P.C.
Jan
17
2024
California's Proposition 65: A Regulatory Conundrum Keller and Heckman LLP
Jan
17
2024
December 2023 Bounty Hunter Plaintiff Claims Keller and Heckman LLP
Jan
17
2024
FDA Approves Florida Importing Drugs from Canada Greenberg Traurig, LLP
Jan
17
2024
FDA Recommends that the DEA Reschedule Marijuana Keller and Heckman LLP
Jan
16
2024
Law Library of Congress Publishes Report on Selected Issues in Biotechnology Regulation Bergeson & Campbell, P.C.
Jan
16
2024
CMS Proposes to Prohibit Overrides in Medicare Advantage McDermott Will & Emery
Jan
16
2024
Groundhog Day: Alabama Dispensary, Integrated Licenses Delayed (Again) Bradley Arant Boult Cummings LLP
Jan
16
2024
Arizona Moves to Ban Lab-Grown Meat Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins